Cefpodoxime Pregnancy and Breastfeeding Warnings
Brand names: Vantin
Medically reviewed by Drugs.com. Last updated on Apr 18, 2025.
Cefpodoxime Pregnancy Warnings
Cefpodoxime has been assigned to pregnancy category B by the FDA. Animal studies failed to reveal evidence of embryotoxicity or teratogenicity. There are no controlled data in human pregnancy. Cefpodoxime should only be given during pregnancy when need has been clearly established.
Cefpodoxime Breastfeeding Warnings
Cefpodoxime is excreted into human milk in small amounts. Adverse effects in the nursing infant are unlikely. Other cephalosporins have been classified as compatible with breast-feeding by the American Academy of Pediatrics.
See also
References for pregnancy information
- (2002) "Product Information. Vantin (cefpodoxime)." Pharmacia and Upjohn
References for breastfeeding information
- (2002) "Product Information. Vantin (cefpodoxime)." Pharmacia and Upjohn
- Briggs GG, Freeman RK, Yaffe SJ.. (1998) "Drugs in Pregnancy and Lactation." Baltimore, MD: Williams & Wilkins
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.